ライフサイエンスコーパス: respiratory illness

1 e East respiratory syndrome-CoV, cause acute respiratory illness.

2 l swabs for the detection of RSV during each respiratory illness.

3 responsible for seasonal epidemics of acute respiratory illness.

4 d monitored for 5 d for the development of a respiratory illness.

5 y recognized as a significant cause of adult respiratory illness.

6 infection is most frequently associated with respiratory illness.

7 e detection of RSV were obtained during each respiratory illness.

8 f enterovirus D68 (EV-D68)-associated severe respiratory illness.

9 ter in 4 states were hospitalized with acute respiratory illness.

10 ted with isolated cases or small clusters of respiratory illness.

11 in the United States associated with severe respiratory illness.

12 ncommon human pathogen, associated with mild respiratory illness.

13 tter understand the role of EV-D68 in severe respiratory illness.

14 one symptom that was consistent with a viral respiratory illness.

15 eumovirus (HMPV) is a leading cause of acute respiratory illness.

16 adults hospitalized with influenza and acute respiratory illness.

17 and coughs of children and adults with acute respiratory illness.

18 data on outcomes of people hospitalized with respiratory illness.

19 sociated with an outbreak of enterovirus-D68 respiratory illness.

20 subset of three of the seven hospitals with respiratory illness.

21 ausing outbreaks of severe, and often fatal, respiratory illness.

22 antibiotic use in patients with likely viral respiratory illness.

23 RT-PCR) after a clinical encounter for acute respiratory illness.

24 samples collected from patients with febrile respiratory illness.

25 4.3%-86.9%) against medically attended acute respiratory illness.

26 the diagnosis of asthma or prior history of respiratory illness.

27 roportion of individuals who sought care for respiratory illness.

28 onavirus disease (COVID-19), a predominantly respiratory illness.

29 rus 2 (SARS-CoV-2), has caused a pandemic of respiratory illness.

30 the leading viral cause of severe pediatric respiratory illness.

31 s (2668 HCP-seasons) when near patients with respiratory illness.

32 accurate reporting of this life-threatening respiratory illness.

33 pulmonary health and the prevention of adult respiratory illness.

34 are a leading cause of seasonal and pandemic respiratory illness.

35 breathing problems, tiring easily, and acute respiratory illnesses.

36 ease, and more than 1.1 million cases of all respiratory illnesses.

37 te differences in the cause and prognosis of respiratory illnesses.

38 , including cardiovascular, oncological, and respiratory illnesses.

39 mens were collected from subjects with acute respiratory illnesses.

40 ssociated with emergency room visits for all respiratory illnesses.

41 c hormonal preparations for the treatment of respiratory illnesses.

42 as first-line treatment for various chronic respiratory illnesses.

43 collected from subjects with reported acute respiratory illnesses.

44 nd this interaction related to S. pneumoniae respiratory illnesses.

45 s, and active surveillance was conducted for respiratory illnesses.

46 tendees had multiple viruses detected during respiratory illnesses.

47 ditions to neurological, cardiovascular, and respiratory illnesses.

48 esses and identified novel associations with respiratory illnesses.

49 nificant differences in hospitalizations for respiratory illness (1.1% compared with 2.2%, respective

50 escribed to 80.5% of children diagnosed with respiratory illness, 50.1% with diarrhoea, and 28.3% wit

51 Influenza-associated respiratory illness accounted for 99.2% (10 576 146) of

52 mplicated in a widespread outbreak of severe respiratory illness across the USA in 2014 and has also

53 In 2014, EV-D68 caused widespread severe respiratory illness across the USA, disproportionately a

54 nd 24 months of age), and during episodes of respiratory illnesses, all of which were analyzed for re

55 ngly available for assessment of acute lower respiratory illnesses (ALRI).

56 with the large outbreak of EV-D68-associated respiratory illness, although direct laboratory evidence

57 ld likely substantially reduce the burden of respiratory illness among children in rural and urban ar

58 Bordetella pertussis causes severe respiratory illness among infants and adolescents.

59 ghts the importance of surveillance for mild respiratory illness among populations frequently exposed

60 HRV-C is increasingly associated with lower respiratory illness among populations such as children a

61 on in future studies of gastrointestinal and respiratory illnesses among infants.

62 nza in a vaccinated child with febrile acute respiratory illness, analysed in the modified intention-

63 dence interval, 30.2%-89.1%) against febrile respiratory illness and 66.4% (95% CI, 14.3%-86.9%) agai

64 ramyxovirus Hendra virus (HeV) causes severe respiratory illness and encephalitis in humans.

65 Henipavirus infection causes severe respiratory illness and encephalitis.

66 ted microbiotas were associated with reduced respiratory illness and exacerbation events, whereas Str

67 vascular disease and secondary outcomes were respiratory illness and fractures.

68 68) is a viral pathogen that leads to severe respiratory illness and has been linked with the develop

69 has been associated with outbreaks of severe respiratory illness and increased cases of nonpolio acut

70 navirus (MERS-CoV) infection causes an acute respiratory illness and is associated with a high case f

71 onal pilot study to identify absences due to respiratory illness and laboratory-confirmed influenza i

72 years admitted to 11 hospitals with an acute respiratory illness and laboratory-confirmed influenza.

73 lt in inappropriate management of paediatric respiratory illness and misdirection of potentially scar

74 es is the largest one associated with severe respiratory illness and neurological complication.

75 cimens from hospitalized patients with acute respiratory illness and outpatients with influenza-like

76 (NiVM), which has caused lower instances of respiratory illness and person-to-person transmission du

77 , we enrolled hospitalized adults with acute respiratory illness and tested each for influenza using

78 Controls were hospitalized with acute respiratory illness and tested negative for influenza.

79 years admitted to 8 US hospitals with acute respiratory illness and testing positive for influenza b

80 tensive care units (PICUs) with acute severe respiratory illness and testing positive for influenza w

81 presented to outpatients clinics with acute respiratory illness and were tested for influenza.

82 Hundreds of cases of respiratory illness and/or dermatitis have been recorded

83 working adults with medically attended acute respiratory illnesses and compared outcomes for subjects

84 es such as vaccination could decrease severe respiratory illnesses and complications in the elderly.

85 es collected from children hospitalized with respiratory illnesses and positive for influenza by age

86 virus (CoV) HKU1 is a pathogen causing acute respiratory illnesses and so far little is known about i

87 collected from subjects with reported acute respiratory illnesses and tested by real-time reverse tr

88 specific associations with more severe viral respiratory illnesses and the risk of virus-induced exac

89 to individual differences in childhood viral respiratory illnesses and virus-induced exacerbations of

90 , five with enterovirus-D68-associated upper respiratory illness, and 16 with aseptic meningitis or e

91 gns and symptoms of diarrheal disease, acute respiratory illness, and anemia.

92 respiratory infections, laboratory-confirmed respiratory illness, and influenzalike illness.

93 posure is known to cause allergic reactions, respiratory illness, and may be responsible for some for

94 phytoplankton and reports of eye irritation, respiratory illness, and rash.

95 rofile for a cohort study of childhood acute respiratory illness, and the library biases were resolve

96 the leading viral cause of severe pediatric respiratory illness, and vaccines are needed.

97 tion, as well as predominant bacteria during respiratory illnesses, and we correlated these with pres

98 We determined the risk of respiratory illness- and RSV-related hospitalizations (R

99 Although many viral respiratory illnesses are transmitted within households,

100 tiviral receipt among outpatients with acute respiratory illness (ARI) and antibiotic receipt among p

101 Acute respiratory illness (ARI) commonly causes outpatient vis

102 We identified inmates with acute respiratory illness (ARI) from 1 November 2009 to 24 Feb

103 Outbreaks of human adenovirus (HAdV) acute respiratory illness (ARI) have been well documented amon

104 years of age who were hospitalized for acute respiratory illness (ARI) in 3 US counties during Octobe

105 d within a prospective cohort study of acute respiratory illness (ARI) in Andean children <3 years of

106 ational studies based on patients with acute respiratory illness (ARI) remain as the only option to e

107 ors from prospective, population-based acute respiratory illness (ARI) surveillance at a large US ped

108 ons vaccinated among 192 controls with acute respiratory illness (ARI) who tested negative for influe

109 nation had 37.7% effectiveness against acute respiratory illness (ARI), 50.3% against a febrile episo

110 ousehold data to measure self-reported acute respiratory illness (ARI), before, during, and after sch

111 ccine for prevention of RSV-associated acute respiratory illness (ARI), defined by specified symptoms

112 ory samples by mail in the event of an acute respiratory illness (ARI).

113 6004 outpatients aged >/=6 months with acute respiratory illness (ARI).

114 cytial virus (RSV) is a major cause of acute respiratory illness (ARI).

115 healthy adults who were monitored for acute respiratory illness (ARI).

116 nths post-partum, to document cases of acute respiratory illness (ARI).

117 appropriate antibiotic prescribing for acute respiratory illnesses (ARI) is patients' prior care expe

118 The severity and rates of rhinovirus acute respiratory illnesses (ARIs) in adults are uncertain.

119 exacerbation of asthma and causes most acute respiratory illnesses (ARIs), which may manifest as infl

120 aditionally been the site for studying acute respiratory illnesses (ARIs).

121 viral (n = 41) or non-viral (n = 100) acute respiratory illnesses (ARIs).

122 primary outcome and rhinovirus infection and respiratory illnesses as secondary outcomes were perform

123 An outbreak of severe respiratory illness associated with enterovirus D68 (EV-

124 ginning in August, 2014, increases in severe respiratory illness associated with EV-D68 were reported

125 ory care patients aged >=6 months with acute respiratory illness at 5 sites.

126 es was examined among outpatients with acute respiratory illness at 5 US sites using a test-negative

127 es was examined among outpatients with acute respiratory illness at 5 US sites using a test-negative

128 from children presenting with upper or lower respiratory illness at acute care visits were tested for

129 ths of age or older who presented with acute respiratory illness at ambulatory care clinics in geogra

130 olled outpatients aged >=6 months with acute respiratory illness at five sites.

131 of Health investigated an outbreak of lower respiratory illnesses at a hospital in Jordan; 2 fatal c

132 tial may modify the impact of PM2.5 on acute respiratory illnesses at low PM2.5 concentrations.

133 ith several human disease conditions such as respiratory illnesses, auto-immune disorders and hepatit

134 , Illinois, and Colorado showed increases in respiratory illness between August and September, 2014,

135 occus species and age of first febrile lower respiratory illness, both of which are known asthma risk

136 nique opportunity to estimate the outpatient respiratory illness burden by etiology.

137 form, while children are largely spared from respiratory illness but can develop a life-threatening m

138 s study: (1) describes the viral etiology of respiratory illness by prospectively collecting weekly s

139 ing for respiratory viruses in patients with respiratory illnesses can provide advantages to patients

140 dictive value of each symptom-predictor, WHO respiratory illness case definitions and a de novo defin

141 Respiratory illness caused by Corynebacterium diphtheria

142 (20.0% vs. 9.9%; P = 0.02); early life lower respiratory illness caused by respiratory syncytial viru

143 ronavirus disease 2019 (COVID-19) is a novel respiratory illness caused by SARS-CoV-2.

144 ronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute respiratory s

145 Pertussis is a highly contagious respiratory illness caused by the bacterial pathogen Bor

146 Respiratory illness caused by viral infection is associa

147 cines in preventing medically attended acute respiratory illnesses caused by influenza.

148 Influenza is an acute respiratory illness, caused by influenza A, B, and C vir

149 RV-C was significantly associated with lower respiratory illness, compared with HRV-A (P = .014).

150 Most cases among residents included respiratory illness consistent with Covid-19; however, i

151 apid PCR testing of adults hospitalized with respiratory illnesses could provide benefits to both the

152 patients.IMPORTANCE The current pandemic of respiratory illness, COVID-19, is caused by a recently e

153 ct of masks and respirators against clinical respiratory illness (CRI) (risk ratio [RR] = 0.59; 95% c

154 Outcomes included clinical respiratory illness (CRI) and laboratory-confirmed respi

155 2 hospitals in southeast Michigan for acute respiratory illnesses, defined by admission diagnoses, o

156 s aged >/=50 years who sought care for acute respiratory illness during 3 influenza seasons: 2008-200

157 Adults hospitalized with respiratory illness during 3 winters underwent comprehen

158 njugate vaccination of their infants against respiratory illness during early infancy.

159 ult populations under surveillance for acute respiratory illness during the winters of 1999-2003.

160 (Ad14) that has caused increased severity of respiratory illnesses during globally distributed outbre

161 d of exacerbation, rhinovirus infection, and respiratory illnesses during the fall season.

162 0 deaths and up to 5 million cases of severe respiratory illness each year.

163 iori definitions of diarrhea and acute lower respiratory illness episodes.

164 type 1 (HPIV1) also causes severe pediatric respiratory illness, especially croup.

165 There were 1556 acute respiratory illness events in the respirator group vs 17

166 to 15.4]; P = .47); 371 laboratory-confirmed respiratory illness events in the respirator group vs 41

167 d 47% with specimen collected </=7 days from respiratory illness/fever onset).

168 V1 are major viral causes of acute pediatric respiratory illness for which no vaccines or suitable an

169 ct of the new adenovirus vaccines on febrile respiratory illness (FRI) and adenovirus rates and inves

170 60s in association with outbreaks of febrile respiratory illness (FRI) in military boot camps and civ

171 viral infections against subsequent febrile respiratory illness (FRI).

172 Among adults hospitalized with respiratory illness from COVID-19, treatment with hydrox

173 y case-control studies exclude controls with respiratory illness from enrollment or analyses.

174 The women were followed up for respiratory illness from midpregnancy and together with

175 boratory-confirmed viral infection; clinical respiratory illness had inconsistency.

176 ng to hospital, but its impact on subsequent respiratory illnesses has not been defined.

177 azard ratio = 2.07, 95% CI: 1.79, 2.40), and respiratory illness (hazard ratio = 2.48, 95% CI: 2.12,

178 tributed to a modest proportion of all-cause respiratory illness hospitalization among black-African

179 tes pneumonia from other causes of childhood respiratory illness, hypoxia and increased work of breat

180 the risk ratio for >=1 diagnosis of a lower respiratory illness (ie, pneumonia or bronchiolitis) dur

181 RSV is a common cause of acute respiratory illness in adults aged >/= 50 years; the ris

182 Data on causes of death due to respiratory illness in Africa are limited.

183 eness (surveillance study) was febrile acute respiratory illness in an unvaccinated household member

184 he host cell machinery to replicate, causing respiratory illness in annual epidemics and pandemics of

185 In a previous study of acute febrile respiratory illness in Bangladesh, we tested paired seru

186 ase cases in North America, including severe respiratory illness in children and acute flaccid myelit

187 is a causative agent of recent outbreaks of respiratory illness in children in the United States.

188 chopulmonary dysplasia (BPD) remains a major respiratory illness in extremely premature infants.

189 HMPV can cause severe respiratory illness in healthy adults and should be cons

190 irus, nCoV, as the causative agent of severe respiratory illness in humans originating in Saudi Arabi

191 us (MERS-CoV) causes severe and often lethal respiratory illness in humans, and no vaccines or specif

192 hat cause neurotoxic shellfish poisoning and respiratory illness in humans, as well as massive fish k

193 yndrome coronavirus (MERS-CoV) causes severe respiratory illness in humans.

194 rus (AdV), a DNA virus that can cause severe respiratory illness in immune-compromised individuals.

195 rtunistic environmental pathogen that causes respiratory illness in immunocompromised patients, such

196 ) infection is a major cause of severe lower respiratory illness in infants and young children, but t

197 syncytial virus (RSV) is the major cause of respiratory illness in infants worldwide.

198 h 2016, we conducted surveillance for severe respiratory illness in infants.

199 ean monthly rate of visits related to severe respiratory illness in June through August of 2019 was t

200 olated from a patient who died from a severe respiratory illness in June, 2012, in Jeddah, Saudi Arab

201 virus (RSV) is an important cause of serious respiratory illness in older adults.

202 ved association between O. cf. ovata blooms, respiratory illness in people, and detection of palytoxi

203 dle East respiratory syndrome," "coronavirus respiratory illness in Saudi Arabia," and "novel (beta)

204 f MERS-CoV infection, or someone with severe respiratory illness in the 14 days before the onset of i

205 Human coronaviruses (hCoVs) cause severe respiratory illness in the elderly.

206 tory disease in infants and a major cause of respiratory illness in the elderly.

207 tory disease in infants and a major cause of respiratory illness in the elderly.

208 cimens from patients in a recent outbreak of respiratory illness in the lower Hudson Valley, New York

209 D68 (EV-D68) caused a widespread outbreak of respiratory illness in the United States in 2014, predom

210 >/=9 years old with medically-attended acute respiratory illness in the US Influenza Vaccine Effectiv

211 >/=9 years old with medically-attended acute respiratory illness in the US Influenza Vaccine Effectiv

212 ignificantly associated with childhood lower respiratory illness in this population for several decad

213 causes acute, and occasionally fatal, lower respiratory illness in young infants, the elderly, and i

214 annual basis and a long history of studying respiratory illnesses in households.

215 T2 variants to reported gastrointestinal and respiratory illnesses in infancy.

216 ther explanation of the refractory nature of respiratory illnesses in smokers and highlight cigarette

217 pitalized for COVID-19, 20% developed severe respiratory illness (including 9% who required mechanica

218 age hospitalized with any sign or symptom of respiratory illness (including suspected sepsis or apnea

219 ngus that has been implicated in a number of respiratory illnesses, including HP.

220 human disease ranging from conjunctivitis to respiratory illnesses, including the 2009-10 A(H1N1)pdm0

221 Severe respiratory illness induced by either of these viruses i

222 Influenza A viruses cause the respiratory illness influenza, which can be mild to fata

223 he identification of multiple viruses during respiratory illness is increasing with advances in rapid

224 The global burden of pediatric severe respiratory illness is substantial, and influenza viruse

225 The role of human bocavirus (HBoV) in respiratory illness is uncertain.

226 The role of HBoV-1 in respiratory illness is unclear, owing to frequent detect

227 outcomes from mild conjunctivitis to severe respiratory illnesses, it is not clear where the HA of t

228 condary outcomes included incidence of acute respiratory illness, laboratory-detected respiratory inf

229 asthma-like symptoms after early-life lower respiratory illness (LRI) caused by respiratory syncytia

230 llowing RSV season, medically attended acute respiratory illness (MAARI) and pre- and postsurveillanc

231 ed >/=6 months with medically attended acute respiratory illness (MAARI), including cough, with illne

232 , and death) due to medically attended acute respiratory illness (MAARI).

233 veness (VE) against medically attended acute respiratory illness (MAARI).

234 Stronger surveillance for deaths due to respiratory illness may identify risk groups for targete

235 fication was common among young infants with respiratory illness, most of whom were too young to be f

236 s of medically attended influenza-associated respiratory illness, obtained from case-based and ecolog

237 Patients with acute respiratory illnesses of </= 7 days' duration were enrol

238 Nasal swabs were collected at respiratory illness onset and every 7-10 days until illn

239 emerging paramyxovirus that can cause fatal respiratory illness or encephalitis in humans.

240 ive, population-based surveillance for acute respiratory illness or fever among inpatient and outpati

241 dical unit of a large UK hospital with acute respiratory illness or fever higher than 37.5 degrees C

242 Two-thirds of the patients had an antecedent respiratory illness or meningitis.

243 est Cyanobacteria counts was associated with respiratory illness (OR = 1.37; 95% CI: 1.12, 1.67), ras

244 ples from 955 children with gastroenteritis, respiratory illness, or both, and found BuV DNA in three

245 contacts in a Jordanian hospital-associated respiratory illness outbreak in April 2012, resulting in

246 nd between rs602662 and gastrointestinal and respiratory illnesses, owing to the high linkage disequi

247 impact of PM2.5 on emergency room visits for respiratory illnesses (P = 0.001) but only at low concen

248 ars, during the 12-week period of peak viral respiratory illness, pairs of outpatient sites (clusters

249 Of those infected there were 69 respiratory illnesses per 100 person-influenza-seasons c

250 of pregnant women in settings of unexplained respiratory illness potentially due to MERS-CoV.

251 ologic features and cause clinically similar respiratory illness predominantly in young children.

252 aeroallergen sensitization and primary care respiratory illness presentations.

253 bs with multiple viruses detected changed as respiratory illnesses progressed from week to week, as d

254 because of impaired lung function or whether respiratory illness reduces lung function.

255 influenza and influenza test-negative acute respiratory illness, respectively.

256 and RSV-associated medically attended acute respiratory illness (RSV-MAARI) and antibody responses d

257 We performed a retrospective analysis of respiratory illness samples from longitudinal cohorts of

258 rld Health Organization-defined severe acute respiratory illness (SARI) (2012-2015) underwent influen

259 influenza-like illness (ILI) or severe acute respiratory illness (SARI) and from asymptomatic control

260 ublic clinics for patients with severe acute respiratory illness (SARI) at 16 regional public hospita

261 uring sentinel surveillance for severe acute respiratory illness (SARI) hospitalization conducted in

262 data from 4 years of pediatric severe acute respiratory illness (SARI) sentinel surveillance in Blan

263 Severe acute respiratory illness (SARI) surveillance began in Jingzho

264 d to participate in a review of severe acute respiratory illness (SARI)-associated deaths identified

265 olled case patients hospitalized with severe respiratory illness (SRI) at 2 hospitals and outpatients

266 1-2016, we conducted surveillance for severe respiratory illness (SRI) in children aged <5 years in 3

267 timates, including only influenza-associated respiratory illness, substantially underestimated influe

268 We used respiratory illness surveillance and HIV testing data ga

269 accination trial in Nepal with weekly infant respiratory illness surveillance, 457 of 605 (75.5%) inf

270 tine diagnostic data for >70 000 episodes of respiratory illness tested molecularly for multiple resp

271 Controls were subjects with acute respiratory illness testing negative for influenza.

272 Human influenza is a highly contagious acute respiratory illness that is responsible for significant

273 birth occurred during the course of an acute respiratory illness that was attributed to MERS-CoV on t

274 nalyzed diagnostic data from 44,230 cases of respiratory illness that were tested for 11 taxonomicall

275 uenza, we developed the Above Local Elevated Respiratory Illness Threshold (ALERT) algorithm, a metho

276 , we enrolled patients admitted due to acute respiratory illness to two public hospitals in Bergen, N

277 Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study coronavirus disease

278 coronavirus disease 2019 Viral Infection and Respiratory Illness Universal Study pandemic registry.

279 Respiratory illness was reported among humans and swine

280 accid myelitis and a sibling with only upper respiratory illness were both infected by identical ente

281 /=50 years who sought medical care for acute respiratory illness were enrolled.

282 tients >/=45 years old presenting with acute respiratory illness were prospectively enrolled during t

283 Patients presenting with acute respiratory illness were prospectively enrolled during t

284 Patients >/= 50 years old with acute respiratory illness were recruited for studies of influe

285 who fulfilled a broad syndromic criteria of respiratory illness were tested for B. pertussis infecti

286 Symptomatic respiratory illnesses were laboratory-confirmed as influ

287 uenza among hospitalized patients with acute respiratory illness when influenza is circulating in a c

288 ng to the emergency department with an acute respiratory illness who met Centers for Disease Control

289 rs old and adults >/=50 years old with acute respiratory illness who participated in seasonal studies

290 seholds containing index patients with acute respiratory illness who tested positive for Yamagata- an

291 esponsible for outbreaks of encephalitis and respiratory illness with fatality rates of 50-100%.

292 coronavirus (SARS-CoV) caused an acute human respiratory illness with high morbidity and mortality in

293 for MERS-CoV in patients with febrile and/or respiratory illness with recent travel to the Arabian Pe

294 ary shedding events are associated with mild respiratory illness with subsequent prolonged detection

295 global concern: the virus has caused severe respiratory illness, with 111 confirmed cases and 52 dea

296 d to prevented cases of infant mortality and respiratory illnesses, with a monetized impact of $8.1 m

297 nfluenza viruses are a common cause of acute respiratory illness worldwide and generate a significant

298 human metapneumovirus are leading causes of respiratory illness worldwide, but limited treatment opt

299 ncytial virus (RSV) is an important cause of respiratory illness worldwide, however, burden data on m

300 ulation and comprise a significant burden of respiratory illnesses worldwide.